Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Jason Ya"'
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95950 (2014)
Lethal factor (LF) is a component of the B. anthracis exotoxin and critical for pathogenesis. The roles of LF in early anthrax pathogenesis, such as colonization and dissemination from the initial site of infection, are poorly understood. In mice mod
Externí odkaz:
https://doaj.org/article/64860c48242b41618647765fb83a2052
Autor:
Anthony P. Fernandez, M. Elaine Husni, Sean E. Mazloom, Di Yan, Jason Ya, Jeffery Hu, Christine B. Warren
Publikováno v:
Journal of the American Academy of Dermatology. 83:1590-1598
Background Tumor necrosis factor-α (TNF-α) inhibitor (TNFI)-induced psoriasis remains poorly understood despite having been described 15 years ago. As TNFIs often provide life-changing patient benefits, understanding effective treatments for TNFI-i
Autor:
Elma D. Baron, Harib H. Ezaldein, Vermen Verallo-Rowel, Pingfu Fu, Jasmin Jamora, Amanda Suggs, Jason Ya, Francine Lu
Publikováno v:
Clocks & Sleep
Clocks & Sleep; Volume 1; Issue 2; Pages: 273-279
Clocks & Sleep; Volume 1; Issue 2; Pages: 273-279
Night shift workers may have a disrupted circadian rhythm, which may contribute to the development of skin disease. The purpose of this study was to determine whether there is a significant difference in the prevalence and severity of self-reported s
Autor:
Mingyuan Sun, Qingsong Yin, Yang Liang, Chunkang Chang, Jing Zheng, Jian Li, Chunyan Ji, Huiying Qiu, Junmin Li, Yuping Gong, Sheng Luo, Yan Zhang, Rumei Chen, Zhenwei Shen, Zenglian Yue, Siyuan Wang, Qingmei Shi, Jason Yang, Jie Jin, Jianxiang Wang
Publikováno v:
Blood Science, Vol 6, Iss 3, p e00196 (2024)
Ivosidenib, an isocitrate dehydrogenase 1 (IDH1) inhibitor, has demonstrated clinical benefits in a pivotal study (AG120-C-001) in patients with IDH1-mutated (mIDH1) acute myeloid leukemia (AML). A registry study (CS3010-101: NCT04176393) was conduct
Externí odkaz:
https://doaj.org/article/f2902b371ae34d948a11a6142a5bb49e
Publikováno v:
ACS Central Science, Vol 10, Iss 2, Pp 226-241 (2024)
Externí odkaz:
https://doaj.org/article/57cae4823c3d4288aa875c1deea9d142
Autor:
Jiah Pearson-Leary, Alexander P. Abramenko, Valerie Estela-Pro, Elizabeth Feindt-Scott, Jason Yan, Abigail Vigderman, Sandra Luz, Debra Bangasser, Richard Ross, Leszek Kubin, Seema Bhatnagar
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Dysfunctional fear responses in post-traumatic stress disorder (PTSD) may be partly explained by an inability to effectively extinguish fear responses elicited by trauma-related cues. However, only a subset of individuals exposed to traumati
Externí odkaz:
https://doaj.org/article/d04c2d2f122b4131bee847a14a8ee9d8
Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma
Autor:
Brian R. Gastman, Pauline Funchain, Evan Stiegel, David D. Xiong, Raymond Isakov, Jason Ya, Alok Vij
Publikováno v:
Journal of the American Academy of Dermatology. 78:942-948
Background Sentinel lymph node (SLN) biopsy is widely performed for melanoma with certain histologic parameters and offers important prognostic and staging information. Breslow thickness (BT) by itself also provides meaningful prognostic information.
Autor:
Joel Nulsen, Nosheen Hussain, Aws Al-Deka, Jason Yap, Khalil Uddin, Christopher Yau, Ahmed Ashour Ahmed
Publikováno v:
BMC Bioinformatics, Vol 24, Iss 1, Pp 1-17 (2023)
Abstract Background Genomic insights in settings where tumour sample sizes are limited to just hundreds or even tens of cells hold great clinical potential, but also present significant technical challenges. We previously developed the DigiPico seque
Externí odkaz:
https://doaj.org/article/a1b03ef623f74a5faaf236a7f568ea75
Autor:
M. Elaine Husni, Jeffery Z. Hu, Sean E. Mazloom, Anthony P. Fernandez, Gowri Kabbur, Jason Ya, Urmi Khanna, Amy S. Nowacki
Publikováno v:
Journal of the American Academy of Dermatology. 83(6)
Background Tumor necrosis factor-α inhibitor–induced psoriasis (TNFI psoriasis) is a paradoxical reaction characterized by development of a psoriasiform rash that mimics psoriasis vulgaris. Temporal onset variability and low incidence rates sugges